FDA
approval
· 2023-10-06
FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Leading Pharma, LLC)
Summary
The FDA approved a supplemental application for imipramine hydrochloride from Leading Pharma, LLC under the ANDA process.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)